Jake Bauer

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.

Raised $65,000,000.00 from SR One, ArrowMark Partners, Biotechnology Value Fund, Logos Capital, Samsara BioCapital and Rock Springs Capital.

Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.

Raised $197,000,000.00 from venBio Partners, Sarissa Capital Management, Vivo Capital, Logos Capital, Surveyor Capital, Bristol-Myers Squibb, Alpha Wave Ventures, Sarissa Capital Management, venBio Partners and Logos Capital.

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Raised $230,000,000.00 from Acuta Capital Partners, Venrock Healthcare Capital Partners, Commodore Capital, Rock Springs Capital, Logos Capital, Fairmount Funds Management and Woodline Partners.

Bristol-Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.

Raised $23,580,000,000.00 from RA Capital Management, OUP (Osage University Partners), Aperture Venture Partners, Greg Bailey, Connecticut Innovations, Knoll Capital Management, Vivo Capital, Venrock, Litmore Capital and Carl Icahn.

MyoKardia is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of rare cardiovascular diseases.

Raised $98,000,000.00 from BridgeBio, Cowen Group, Casdin Capital, Cormorant Asset Management and Perceptive Life Sciences.

Ablexis is a biotechnology company developing an innovative, next-generation platform for antibody drug discovery.

Raised $12,000,000.00 from Third Rock Ventures and Pfizer Venture Investments.